Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

KLF4 is important for maintaining skin stem cells and helps heal wounds.

Alopecia Areata can develop without perforin-mediated cytolysis.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Platelet lysate could be a valuable treatment for many diseases in regenerative medicine.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Biological therapy boosts the immune system to effectively fight melanoma.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.